AddBio AB
Introducing a groundbreaking bioactive nanoparticle for orthopedic and dental implants that delivers an advanced bone enhancement drug.
Introducing a groundbreaking bioactive nanoparticle for orthopedic and dental implants that delivers an advanced bone enhancement drug.
AddBio AB is a biotechnology startup that was founded in 2008. The company has developed Zolidd®, a proprietary bioactive nanoparticle designed for orthopedic and dental implants. This groundbreaking product delivers bisphosphonate, a bone enhancement drug, aiming to revolutionize the field by providing advanced bone enhancement. The company received a kr9.40M Venture Round investment on April 17, 2012 from Almi Invest, showcasing confidence and support from notable investors. This injection of capital reflects the potential and promise that AddBio AB holds.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | kr9.40M | 1 |
|
17 Apr 2012 |
No recent news or press coverage available for AddBio AB.
We care about your data, and we'd love to use cookies make your experience better.
